4.7 Article

Liquid chromatography with time-of-flight mass spectrometry for simultaneous determination of chemotherapeutant residues in salmon

Journal

ANALYTICA CHIMICA ACTA
Volume 562, Issue 2, Pages 176-184

Publisher

ELSEVIER
DOI: 10.1016/j.aca.2006.01.075

Keywords

chemotherapeutant residues; salmon; liquid chromatography; time-of-flight mass spectrometry

Ask authors/readers for more resources

Liquid chromatography with time-of-flight mass spectrometry (LC-TOF-MS) method has been developed for simultaneous confirmation by accurate mass measurement and quantitative determination of antibiotics (enrofloxacin, oxolinic acid, flumequine, erythromycin), fungicides (malachite green MG, leucomalachite green LMG) and parasiticide (emamectin benzoate) residues in edible portion of salmon. Confirmation of chemotherapeutant residues has been based on the system of identification points (IPs) established in the Commission Decision 2002/657/EC concerning the use of mass spectrometry (MS) techniques. A validation study on matrix is presented evaluating accuracy in terms of precision (lambda(ppm) 0.83-1.15) and trueness (0.22-0.70 Da). Limits of detection (LODs) and limits of quantification (LOQs) were in ranges of 1-3 and 3-9 mu g/kg, below the maximum residue limits (MRLs) established in current EU legislation (100-200 mu g/kg) for these chemotherapeutants. Considering the EU guidelines, decision limits (CC alpha) and detection capabilities (CC beta) were determined (ranges of 103-218 and 107-234 mu g/kg, respectively) for authorised substances. For no authorised compounds (MG and LMG), LODs were 2 and 1 mu g/kg, respectively, but exceed the MRPL (minimum required performance limit) established in the legislation which corresponds to the sum of MG and LMG (2 mu g/kg). Acceptable intra-day and inter-day variability, in terms of relative standard deviation (R.S.D.) of the analytical method, were obtained (2-15%). Linearity was demonstrated from the LOQs of the analytes to 600 mu g/kg (r > 0.9991). The method has involved an extraction procedure based on solid-liquid extraction (SLE) with recoveries higher than 80% for most target chemotherapeutants, with exception of enrofloxacin (40%). (c) 2006 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available